|
Volumn 30, Issue 27, 2012, Pages 3426-3427
|
Before we throw out progression-free survival as a valid end point...
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER CHEMOTHERAPY;
CANCER MORTALITY;
CANCER SURVIVAL;
HUMAN;
LETTER;
LUNG NON SMALL CELL CANCER;
OVERALL SURVIVAL;
POST TREATMENT SURVIVAL;
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
TUMOR GROWTH;
TUMOR VOLUME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
HUMANS;
NEOPLASMS;
OUTCOME ASSESSMENT (HEALTH CARE);
QUALITY OF LIFE;
|
EID: 84866770750
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2012.44.1220 Document Type: Letter |
Times cited : (7)
|
References (8)
|